DNA08: ARGX-113-2315
Clinical Trial Grant
Awarded By
Argenx BVBA
Start Date
March 3, 2025
End Date
March 31, 2030
Awarded By
Argenx BVBA
Start Date
March 3, 2025
End Date
March 31, 2030